Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1979 Mar;36(3):391–397.

Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.

H A Verbrugh, W C Van Dijk, R Peters, M E Van Der Tol, P K Peterson, J Verhoef
PMCID: PMC1457553  PMID: 108204

Abstract

Staphylococcus aureus opsonization was studied kinetically by: (1) determination of the uptake of [3H]-thymidine labelled bacteria by human PMN's; (2) fluorescent anti-C3 and anti-IgG staining of opsonized bacteria; and (3) measuring bacterial complement consumption. Maximum opsonization in normal serum occurred within 5 min of incubation. About 80% of staphylococci were then taken up by PMN's, and IgG and C3b could be detected on the bacterial surface. In the absence of a functional classical complement pathway, as in sera deficient in C1s and C2 and in MgEGTA chelated serum, maximal opsonization was only achieved after 30--60 min incubation. Opsonization in IgG deficient serum occurred at a rate similar to that found in C2 deficient or MgEGTA chelated serum. Opsonization was greatly enhanced when sera were reconstituted. It was concluded that in IgG deficient serum Staphylococcus aureus opsonization is mediated via the alternative complement pathway. Dilution of normal serum primarily affected the classical complement pathway, resulting in a decreased rate of opsonization. In normal serum IgG did not appear to be a rate-limiting factor. S. Aureus opsonization was best studied by the phagocytosis assay and the fluorescent-antibody technique. Measuring haemolytic complement consumption was found to be an insensitive indicator of bacterial complement activation and opsonization.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjornson A. B., Bjornson H. S. Activation of complement by opportunist pathogens and chemotypes of Salmonella minnesota. Infect Immun. 1977 Jun;16(3):748–753. doi: 10.1128/iai.16.3.748-753.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Forsgren A., Quie P. G. Influence of the alternate complement pathway in opsonization of several bacterial species. Infect Immun. 1974 Aug;10(2):402–404. doi: 10.1128/iai.10.2.402-404.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Giebink G. S., Verhoef J., Peterson P. K., Quie P. G. Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV. Infect Immun. 1977 Nov;18(2):291–297. doi: 10.1128/iai.18.2.291-297.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Humphreys D. W., Wheat L. J., White A. Staphylococcal heat-stable opsonins. J Lab Clin Med. 1974 Jul;84(1):122–128. [PubMed] [Google Scholar]
  5. Jasin H. E. Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation. J Immunol. 1972 Jul;109(1):26–31. [PubMed] [Google Scholar]
  6. Johnson F. R., Agnello V., Williams R. C., Jr Opsonic activity in human serum deficient in C2. J Immunol. 1972 Jul;109(1):141–145. [PubMed] [Google Scholar]
  7. Laxdal T., Messner R. P., Williams R. C., Jr, Quie P. G. Opsonic, agglutinating, and complement-fixing antibodies in patients with subacute bacterial endocarditis. J Lab Clin Med. 1968 Apr;71(4):638–653. [PubMed] [Google Scholar]
  8. Mickenberg I. D., Root R. K., Wolff S. M. Leukocytic function in hypogammaglobulinemia. J Clin Invest. 1970 Aug;49(8):1528–1538. doi: 10.1172/JCI106370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Peterson P. K., Verhoef J., Sabath L. D., Quie P. G. Effect of protein A on staphylococcal opsonization. Infect Immun. 1977 Mar;15(3):760–764. doi: 10.1128/iai.15.3.760-764.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Peterson P. K., Wilkinson B. J., Kim Y., Schmeling D., Douglas S. D., Quie P. G., Verhoef J. The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest. 1978 Mar;61(3):597–609. doi: 10.1172/JCI108971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pondman K. W., Hannema A., Cormane R., Stoop J. W. Ongewone complementdeficiëntie bij een patiëntje met lupus erythematosus disseminatus. Ned Tijdschr Geneeskd. 1969 Aug 23;113(34):1462–1469. [PubMed] [Google Scholar]
  12. Stossel T. P., Field R. J., Gitlin J. D., Alper C. A., Rosen F. S. The opsonic fragment of the third component of human complement (C3). J Exp Med. 1975 Jun 1;141(6):1329–1347. doi: 10.1084/jem.141.6.1329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Stossel T. P. Phagocytosis: recognition and ingestion. Semin Hematol. 1975 Jan;12(1):83–116. [PubMed] [Google Scholar]
  14. Verbrugh H. A., Peters R., Peterson P. K., Verhoef J. Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes. J Clin Pathol. 1978 Jun;31(6):539–545. doi: 10.1136/jcp.31.6.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Verhoef J., Peterson P., Kim Y., Sabath L. D., Quie P. G. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains. Immunology. 1977 Aug;33(2):191–197. [PMC free article] [PubMed] [Google Scholar]
  16. Wheat L. J., Humphreys D. W., White A. Opsonization of staphylococci by normal human sera: the role of antibody and heat-labile factors. J Lab Clin Med. 1974 Jan;83(1):73–78. [PubMed] [Google Scholar]
  17. Williams R. C., Jr, Quie P. G. Opsonic activity of agammaglobulinemic human sera. J Immunol. 1971 Jan;106(1):51–55. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES